For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

Learn how to write cleaner Python with enumerate, zip, generator expressions, itertools, and functional tools for readable, memory-efficient data processing.

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

Factorial Energy Inc. targets high-value battery markets, leveraging superior performance for early aerospace and drone applications before scaling to automotive. FAC is rated ‘Buy’ based on its ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.

Factorial Energy (FAC) up 13.9% in Tuesday's trading as Oppenheimer initiated coverage with an Outperform rating and $8 price target, seeing the company as a leading play in the commercialization of ...

For years now Tim Holme has watched the same drama repeat itself roughly once a week. A headline arrives: some laboratory somewhere has cracked the problem, invented the battery of the future, solved ...

Factorial Energy expects initial commercial revenue in 2027, supported by its first commercial drone-battery order and an existing supercar order. Drone testing with Tulip reportedly delivered more ...

BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE)-- Factorial Energy Inc. ("Factorial") (Nasdaq: FAC), a global leader in solid-state battery technology, today announced financial and business results for the ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...